Concepedia

Marcus Gerlach

MG

9

Publications

220

Citations

9

H-Index

2018

Active since

Affiliations

Humboldt-Universität zu Berlin(Current)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie

Ludwig-Maximilians-Universität München

Center for Integrated Protein Science Munich

Urologische Klinik München

Marcus Gerlach is an author at Humboldt-Universität zu Berlin specializing in antibody engineering, medicine, and natural sciences.

ORCID

Top concepts

Publications per year

2018–2023

9

Publications

9

Ethynylphosphonamidates for the Rapid and Cysteine‐Selective Generation of Efficacious Antibody–Drug Conjugates

Marc‐André Kasper, Andreas Stengl, Philipp Ochtrop et al. · Angewandte Chemie International Edition · 2019 · 66 citations · Full text

Targeting FLT3 with a new-generation antibody-drug conjugate in combination with kinase inhibitors for treatment of AML

Maike Roas, Binje Vick, Marc‐André Kasper et al. · Blood · 2022 · 32 citations · Full text

, , +19

Two‐fold Bioorthogonal Derivatization by Different Formylglycine‐Generating Enzymes

Tobias Krüger, Stefanie Weiland, Georg Falck et al. · Angewandte Chemie International Edition · 2018 · 30 citations

Site-Specific Conjugation Strategy for Dual Antibody–Drug Conjugates Using Aerobic Formylglycine-Generating Enzymes

Mareile Boschanski, Tobias Krüger, Lennard Karsten et al. · Bioconjugate Chemistry · 2021 · 25 citations

<i>N</i>‐Hydroxysuccinimide‐Modified Ethynylphosphonamidates Enable the Synthesis of Configurationally Defined Protein Conjugates

Marc‐André Kasper, Marcus Gerlach, Anselm F. L. Schneider et al. · ChemBioChem · 2019 · 17 citations · Full text

Rows per page

1–5 of 9